Takeda Pharmaceutical Quote - TAK

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

14.05

Bid

Ask

Volume

4,505

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

44.089B

Previous Close

13.65

Open

Last Trade

14.06

Last Trade Time

07:07:31

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

3,138,026,928

Dividend Yield

4.35%

PE Ratio

1.07

Earnings Per Share (EPS)

45.91

Revenue

4.28T

Net Profit

144.07B

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geogr... Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Diversified

Website

www.takeda.co.jp

Headquarters

Chuo, Tokyo, Jpn

Founded

1984

Takeda Pharmaceutical Company Ltd is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker TAK. The last closing price for Takeda Pharmaceutical was US$13.65. Over the last year, Takeda Pharmaceutical shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Takeda Pharmaceutical currently has 3,138,026,928 shares outstanding. The market capitalization of Takeda Pharmaceutical is US$42.83 billion. Takeda Pharmaceutical has a price to earnings ratio (PE ratio) of 1.07.

Indiva Announces Commencement of Court-Approved Sale Process

As previously disclosed, on June 13, 2024, Indiva Limited (“Indiva”) (TSXV:NDVA) and its subsidiaries (collectively, the “Indiva Group”) were granted creditor protection pursuant to an order (as...

Indiva Provides Update on SNDL Loan and Strategic Review

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to provide an update to the information contained in its press release dated...

Indiva Reports First Quarter 2024 Results

Indiva Remains the National Market Share Leader in the Edibles Category Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to...

Indiva to Report First Quarter Results Pre-Market on Thursday May 23, 2024

Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles, will report its results for the three months ended March 31, 2024 pre-market on...

Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income From Operations

Indiva Remains the National Market Share Leader in the Edibles Category and Ranks #2 Nationally in Unit Share Across All Cannabis Categories Indiva Limited (the "Company" or "Indiva...

Indiva to Report Fourth Quarter and Full Year Results Pre-Market on Thursday, April 25, 2024

Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles, will report its results for the year ended December 31, 2023 pre-market on Thursday...

Indiva Provides Update on SNDL Loan and Retains Financial Advisor To Evaluate Strategic Alternatives

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce that the Company has entered into an amendment (the "Amending...

INDIVA ANNONCE LE DÉPÔT DE LA VERSION MODIFIÉE ET MISE À JOUR D’UN DOCUMENT D’OFFRE ET UN PLACEMENT PRIVÉ SIMULTANÉ D’UN MONTANT MAXIMAL DE 4,3 MILLIONS DE DOLLARS

NE PAS TRANSMETTRE AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS Indiva Limited (la « Société » ou « Indiva ») (TSXV : NDVA), principal producteur de produits de cannabis...

Indiva Announces Filing of Amended and Restated Offering Document and Concurrent Private Placement of up to $4.3 Million

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce that, it has filed an amended and restated offering document...

INDIVA ANNONCE UN PLACEMENT PRIVÉ SOUS LE RÉGIME DE LA DISPENSE POUR FINANCEMENT DE L’ÉMETTEUR COTÉ D’UN MAXIMUM DE 4 000 000 $

NE PAS TRANSMETTRE AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS. Indiva Limited (la « Société » ou « Indiva ») (TSXV : NDVA), le premier producteur de produits de cannabis...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VSTVistra Corp	US$ 78.90 (14.35%)	51.29k
CPSCooper Standard Holdings Inc	US$ 16.00 (11.42%)	2
ACELAccel Entertainment Inc	US$ 12.22 (10.29%)	76
AMTDAMTD IDEA Group	US$ 1.70 (9.68%)	2.39k
FRGEForge Global Holdings Inc	US$ 1.59 (9.66%)	54
PENPenumbra Inc	US$ 144.00 (-16.81%)	11.98k
OIOI Glass Inc	US$ 9.81 (-15.58%)	16.99k
DESPDespegar com Corp	US$ 10.30 (-11.82%)	1
PEOAdams Natural Resources Fund Inc	US$ 21.39 (-11.76%)	200
LMNDLemonade Inc	US$ 20.06 (-11.36%)	79.14k
LUMNLumen Technologies Inc	US$ 2.65 (-0.75%)	1.24M
NIONIO Inc	US$ 4.55 (2.94%)	619.73k
FFord Motor Company	US$ 10.95 (1.01%)	611.62k
BABoeing Co	US$ 189.5878 (1.46%)	467.12k
TSMTaiwan Semiconductor Manufacturing Co Ltd	US$ 162.40 (5.09%)	410.68k